Table 1 Baseline characteristics
|  | All patients (n = 95) | LVH - (n = 53) | LVH + (n = 42) | P-value |
|---|---|---|---|---|
Age, years | 60.0 (50.0–71.0) | 59.0 (49.5–68.0) | 64 (51.0–72.0) | 0.258 |
Males, n (%) | 72 (75.8%) | 43 (81.1%) | 29 (69.0%) | 0.172 |
Height, m | 1.72 (1.66–1.80) | 1.72 (1.66–1.81) | 1.72 (1,66–1.79) | 0.642 |
Weight, kg | 79.0 (68.5–95.0) | 86.0 (66.0–102.0) | 74.6 (69.0–88.0) | 0.066 |
BMI, kg/m2 | 26.3 (23.9–31.2) | 27.9 (23.8–32.4) | 25.4 (23.9–28.5) | 0.119 |
BSA, m2 | 1.97 (1.79–2.16) | 2.02 (1.77–2.22) | 1.90 (1.79–2.10) | 0.121 |
Height2.7 | 4.3 (3.9-4.9) | 4.3 (3.9-4.9) | 4.3 (3.9-4.8) | 0.756 |
Co-morbidities, n (%) | Â | Â | Â | Â |
Hypertension | 86 (90.5) | 48 (90.6) | 38 (90.5) | 1.000 |
CV events | 15 (15.8) | 8 (15.1) | 7 (16.7) | 0.835 |
CHD | 33 (34.7) | 19 (35.8) | 14 (33.3) | 0.798 |
Heart failure | 5 (5.3) | 3 (5.7) | 2 (4.8) | 1.000 |
Diabetes mellitus | 28 (29.5) | 13 (24.5) | 15 (35.7) | 0.235 |
Medication, n (%) | ||||
 Beta-blocker | 64 (67.4) | 30 (56.6) | 34 (81.0) | 0.012 |
 RAS blockade | 52 (54.7) | 24 (45.3) | 28 (66.7) | 0.038 |
 Diuretics | 50 (52.6) | 24 (45.3) | 26 (61.9) | 0.107 |
 CCB | 44 (46.3) | 21 (39.6) | 23 (54.8) | 0.142 |
 Statins | 29 (30.5) | 16 (30.2) | 13 (31.0) | 0.936 |
Dialysis characteristics | ||||
 Dialysis duration, months | 42.5 (16.8–79.0) | 45.0 (17.0–69.0) | 42.0 (16.0–85.0) | 0.750 |
 Fistula, n (%) | 88 (92.6) | 48 (90.6) | 40 (95.2) | 0.148 |